Daewoong Co., Ltd.

₩16,100As of Sun 8 Nov 2026, 12:00 UTC
KRX:003090Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 6.90%
Div yield 1.24%
ROE 12.89%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.26
PE TTM 3.720
TSR TTM (24.97%)
Mkt cap ₩676.8B
ROIC 8.78%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩17,236
7.06%
(81.84%)
Buy 4|0|4|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
272.66
294.59
321.65
348.47
24.52%
34.32%
39.37%
35.59%
Revenue₩B
29.53
30.72
32.49
32.72
0.57%
5.86%
10.20%
9.04%
Peers (US$499.0M)
Cap (US$)
PE
612.0M
10.54x
529.1M
5.939x
Capital
TTM
5Y
10Y
Leveragex
0.238
0.412
0.408
EBIT/Intx
1.689
0.338
0.322
Own earn%
70.02
0.39
11.25
Sh yield%
21.55
29.38
25.63
Owners
Insiders/Inst%
0.60
45.81
Short interest%
2.96
SBC / revenue%
4.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
8–16
$1 testx
—
Incr. ROIC%
10